J. RandolphHechtMD
Oncology • Los Angeles, CAGastrointestinal Cancer
Professor of Clinical Medicine; Director UCLA GI Oncology Program
Dr. Hecht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Medical 420 530 120 Plz
# 365
Los Angeles, CA 90095Phone+1 310-586-2097Fax+1 310-586-0841
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1997- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1988 - 1991
University of ChicagoFellowship, Research, 1987 - 1988
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
Eastern Virginia Medical SchoolClass of 1984
Certifications & Licensure
CA State Medical License 1988 - 2025
IL State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- A Study of SGN-EGFRd2 in Advanced Solid Tumors Start of enrollment: 2023 Nov 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 5 citationsFecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.Kayti Luu, Jason Y Ye, Venu Lagishetty, Fengting Liang, Megan Hauer
Nutrients. 2023-01-09 - 5 citationsPreclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.Zev A Wainberg, Arun S Singh, Gottfried E Konecny, Kelly E McCann, J Randolph Hecht
Clinical Cancer Research. 2023-01-04 - 10 citationsDiscovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.Na Sun, Yingying Yang, Hui Miao, Peter Redublo, Hongtao Liu
Biosensors & Bioelectronics. 2022-03-01
Lectures
- A phase 1b/2, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into primary and metastatic liver tumors alone and in c...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
